SEC Form D · Amendment · filed September 21, 2022
Triumvira Immunologics Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Jon C. Irvin · AUSTIN, TXExecLee M. Cooper · AUSTIN, TXDirectorElizabeth C. Williams · AUSTIN, TXDirectorCynthia M. Collins, Mba · AUSTIN, TXDirectorDaniel C. Janse · AUSTIN, TXDirectorPaul Lammers, Md, Msc · AUSTIN, TXExec · DirectorWidya M. Mulyasasmita · AUSTIN, TXDirectorBrian M. Bloom · AUSTIN, TXDirectorTeresa C. Mcroberts · AUSTIN, TXExecScott M. Smith · AUSTIN, TXDirectorJurgen M. Eckhardt · AUSTIN, TXDirectorAdam Castelbaum · PHILADELPHIA, PADirectorEric G. Schutt · JANESVILLE, WIDirectorDavid Linton · Snohomish, WADirectorDavid A. Newberg · JANESVILLE, WIExec · DirectorGregory D. Smith · JANESVILLE, WIDirectorDennis Tilley · Seattle, WADirectorAndrew Cunningham · Washington, Washington, D.C.ExecJacob Bond · Vancouver, WADirectorRobert F. Bierig · Chicago, ILExecGregory R. Piefer · JANESVILLE, WIDirectorJeremy Burger · Seattle, WADirectorVernon D. Gair Jr · Chicago, ILDirectorAndrea K. Jackson · Madison, WIDirectorSteven K. Galson · Madison, WIExec · DirectorManeesh K. Arora · Madison, WIDirectorPaul K. Berns · Madison, WIDirectorBrandon Arvanaghi · Miami Beach, FLDirectorDanting Wang · Grand Cayman, Cayman IslandsExecYiran Liu · Grand Cayman, Cayman IslandsExecDanting Wang · Grand Cayman, Cayman IslandsDirectorKennedy Lewis Investments Holdings II LLC · New York, NYDirectorJames S. Corl · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗